← Back to headlines
Abbott Laboratories Receives FDA Clearance and CE Mark for Ultreon 3.0 Software
Abbott Laboratories (ABT) has received both FDA Clearance and the CE Mark for its next-generation Ultreon™ 3.0 Software, expanding its availability.
1 May, 07:59 — 1 May, 07:59
Sources
Showing 1 of 1 sources
Related Stories
Meta Agrees to $18 Billion Settlement Over Youth Safety on Social Media
26m ago
Andreessen Horowitz Launches $1.1 Billion Fund for AI Infrastructure Development
39m ago
Marvell Shares Fall Despite Strong Earnings as Google AI Revenue Timing Concerns Persist
42m ago
French Quantum Computing Firm Pasqal Surges in Successful Nasdaq Debut
1h ago